Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

GINKGO BIOWORKS HOLDINGS, INC.

(DNA)
  Report
Real-time Estimate Cboe BZX  -  02:30 2022-09-26 pm EDT
2.785 USD   -0.54%
09/20Zymergen Investor Alert By The Former Attorney General Of Louisiana : Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Zymergen - ZY
PR
09/13The White House - Renee Wegrzyn Slated to Lead New Advanced Research Projects Agency for Health
AQ
09/12Biden executive order to fund U.S. biomanufacturing industry
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sector Update: Health Care Stocks Struggle Tuesday

07/05/2022 | 04:09pm EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
GINKGO BIOWORKS HOLDINGS, INC. -0.36% 2.785 Delayed Quote.-66.31%
INVIVYD, INC. 4.88% 3.12 Delayed Quote.-59.09%
NASDAQ COMPOSITE -0.46% 10821.7 Real-time Quote.-30.53%
NOVAVAX, INC. -7.00% 19.54 Delayed Quote.-85.32%
OUTLOOK THERAPEUTICS, INC. -2.56% 1.14 Delayed Quote.-13.97%
All news about GINKGO BIOWORKS HOLDINGS, INC.
09/20Zymergen Investor Alert By The Forme : Kahn Swick & Foti, LLC Investigates Adequacy of Pri..
PR
09/13The White House - Renee Wegrzyn Slated to Lead New Advanced Research Projects Agency fo..
AQ
09/12Biden executive order to fund U.S. biomanufacturing industry
RE
09/01Ginkgo Bioworks Appoints Dr. Behzad Mahdavi as Senior Vice President of Biopharma Manuf..
PR
09/01Ginkgo Bioworks Appoints Behzad Mahdavi as Senior Vice President of Biopharma Manufactu..
CI
08/24Ayana Bio Announces Appointment of Frank Jaksch as Chief Executive Officer
PR
08/19Sector Update: Health Care Stocks Cross Friday Finish Line Slightly Higher
MT
08/19Sector Update: Health Care
MT
08/19Ginkgo Bioworks Acquires Epidemiological Data Infrastructure Assets From Baktus
MT
08/19Ginkgo Bioworks Announces Strategic Purchase of Epidemiological Data Infrastructure Ass..
PR
More news
Analyst Recommendations on GINKGO BIOWORKS HOLDINGS, INC.
More recommendations
Financials (USD)
Sales 2022 430 M - -
Net income 2022 -1 886 M - -
Net cash 2022 1 454 M - -
P/E ratio 2022 -2,48x
Yield 2022 -
Capitalization 4 847 M 4 847 M -
EV / Sales 2022 7,89x
EV / Sales 2023 9,04x
Nbr of Employees 641
Free-Float 53,3%
Chart GINKGO BIOWORKS HOLDINGS, INC.
Duration : Period :
Ginkgo Bioworks Holdings, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GINKGO BIOWORKS HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 2,80 $
Average target price 7,98 $
Spread / Average Target 185%
EPS Revisions
Managers and Directors
Jason Kelly Co-Founder
Reshma Shetty Co-Founder
Mark Dmytruk Chief Financial Officer
Marijn E. Dekkers Independent Director
Bartholomew Canton Chief Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
GINKGO BIOWORKS HOLDINGS, INC.-66.31%4 847
MODERNA, INC.-51.32%48 368
IQVIA HOLDINGS INC.-32.86%35 330
LONZA GROUP AG-41.68%33 599
SEAGEN INC.-9.96%25 673
ALNYLAM PHARMACEUTICALS, INC.18.40%24 099